Environmental impact and costs of a switching program of intravenous to subcutaneous infliximab in Inflammatory Bowel Disease

Oliveira, R.Roseira, J.Araújo, N.Cavaco, C.André, J.Sousa, M.Sousa, H. Tavares deCunha, M.2025-03-062025-03-062025-011873-99461876-4479http://hdl.handle.net/10400.1/26862We aimed to compare real-life direct and indirect costs and the environmental impact of switching IBD patients from IV to SC infliximab (IFX).engEnvironmental impact and costs of a switching program of intravenous to subcutaneous infliximab in Inflammatory Bowel Diseaseconference object10.1093/ecco-jcc/jjae190.1058